Systemic linoleic and gamma-linolenic acid therapy in dry eye syndrome with an inflammatory component.
about
Relation between dietary n-3 and n-6 fatty acids and clinically diagnosed dry eye syndrome in womenThe pathophysiology, diagnosis, and treatment of dry eye diseaseManaging Sjögren's Syndrome and non-Sjögren Syndrome dry eye with anti-inflammatory therapy.Omega-3 essential fatty acids therapy for dry eye syndrome: a meta-analysis of randomized controlled studies.Essential fatty acids in the treatment of dry eye syndrome: A myth or reality?Dry eye disease: A review of diagnostic approaches and treatmentsOral sea buckthorn oil attenuates tear film osmolarity and symptoms in individuals with dry eye.Effect of Korean Red Ginseng supplementation on dry eye syndrome in glaucoma patients - A randomized, double-blind, placebo-controlled study.The international workshop on meibomian gland dysfunction: report of the subcommittee on the epidemiology of, and associated risk factors for, MGDNutritional supplements for dry eye syndromeA review on recent advances in dry eye: Pathogenesis and managementEfficacy of a new prescription-only medical food supplement in alleviating signs and symptoms of dry eye, with or without concomitant cyclosporine A.Expert opinion in the management of aqueous Deficient Dry Eye Disease (DED).Ocular surface immunity: homeostatic mechanisms and their disruption in dry eye diseaseUse of linseed oil to treat experimentally induced keratoconjunctivitis sicca in rabbitsDry eye disease: an immune-mediated ocular surface disorder.The Association between Symptoms of Dry Eye Syndrome and Metabolic Outcome in a General Population in KoreaEffect of Oral Re-esterified Omega-3 Nutritional Supplementation on Dry Eyes.The role of inflammation and antiinflammation therapies in keratoconjunctivitis sicca.Pharmacotherapy of dry eye.New agents for treating dry eye syndrome.Towards a dynamic customised therapy for ocular surface dysfunctions.Changing trends in the treatment of dry-eye disease.The role and treatment of inflammation in dry eye disease.Clinical impact of inflammation in dry eye disease: proceedings of the ODISSEY group meeting.Diagnostic procedures and management of dry eye.Dry Eye Management: Targeting the Ocular Surface Microenvironment.Polyunsaturated fatty acids induce modification in the lipid composition and the prostaglandin production of the conjunctival epithelium cells.Gamma-Linolenic Acid Suppresses NF-κΒ Signaling via CD36 in the Lipopolysaccharide-Induced Inflammatory Response in Primary Goat Mammary Gland Epithelial Cells.Comparison between fish and linseed oils administered orally for the treatment of experimentally induced keratoconjunctivitis sicca in rabbits.Dry eye syndrome.Treating ocular surface disease: new agents in developmentScientific Opinion on the substantiation of health claims related to linoleic acid (LA) in combination with gamma-linolenic acid (GLA) and reduction of ocular dryness (ID 4274) pursuant to Article 13(1) of Regulation (EC) No 1924/2006Evaluation of a novel dry eye model induced by oral administration of finasteride.The Pathophysiology of Dry Eye Disease: What We Know and Future Directions for Research.Aceclofenac oil drops: characterization and evaluation against ocular inflammation.A multicentre, double-masked, randomized, controlled trial assessing the effect of oral supplementation of omega-3 and omega-6 fatty acids on a conjunctival inflammatory marker in dry eye patients.Effects of Aging in Dry Eye.Current and emerging therapy of dry eye disease. Part A: pharmacological modalities
P2860
Q24537414-C3F9C3F0-F2CC-4B18-AD28-E646B7130C19Q28083825-1F3C3369-63ED-4EAC-87DC-A89D18BDD725Q34028408-EABEC8B9-F565-49FA-8A17-1F75CD990AD4Q34194231-6DC895EF-FA17-4033-AD4B-0B541925D3F3Q34273267-F446F730-10D9-44C8-93A8-791FC7F374C3Q34273384-424EEA04-5FBE-4627-AEC3-9613B177A5A6Q34620626-BECD91E1-DB17-4F38-B345-4E0AB0BE04E2Q34719257-A1DC07D2-61B0-4FD9-AC01-26A186CCAAADQ34769309-6E976450-D4CF-414F-B15B-E6E722314BB9Q35163639-F84610F0-E7C4-437D-B4FC-CDDE88499673Q35176597-8E4DF0B5-60A7-43C0-A517-7F9C460E3672Q35233288-5D56E790-01F3-429E-87AE-BF28493AA11EQ35805082-A25FE1F0-62F8-41A1-974B-608A12D1AD02Q35907009-A03D7F18-AD75-47BE-B946-2D2F7494C7B1Q36659458-443D87DC-31EB-4995-BEAF-46856035C37BQ36916372-553EF107-9203-48CC-8530-60B8810E57A0Q36989827-D6C52655-ADDE-4926-96FC-B790979D5F0AQ37155783-9BE28468-5411-4FE6-8C3C-6478344FED5CQ37257746-C6C0E133-E83C-4C6B-BC4A-AFAF0331EA0FQ37826752-13C4DF99-8164-4A0F-A5EE-4D814F3FFE2EQ38058002-FB242AA5-670A-4EE2-A72A-58AE76847CEBQ38098900-EA1B64EE-AFD7-4E79-964C-512A0D2F4016Q38148616-14A8C25A-F49A-4D84-BBA0-24C274C32AA5Q38270449-3AF6E79E-104D-4D41-B66D-08BD9BC27407Q38733230-73F88F74-BB48-4D35-833C-058153D9AA4BQ39352252-4AA97A64-54F0-4A22-A37A-EA0F8D0FD0E6Q39404635-D886901D-C2B6-44BB-8BC7-3F4D5356D30AQ39479125-FA9998EF-71B7-4201-A0B1-4713FEE0106EQ39816791-077BD173-9675-4901-90EC-97496EDFC8B1Q42373406-F324FB89-384F-4A67-90E2-383BD8B517AEQ42578739-F4D74B51-4E01-45C1-865E-9AE098E5CF9FQ42729437-440ACF2E-11F4-4A02-A853-8F15645DB9F9Q47150193-752C3392-A297-44A9-A209-194C733D33D6Q47778585-C7E7360C-84BA-4567-970F-B6E6AE9F0696Q47884949-864F5776-9BAE-428A-95B8-C08922711EA0Q48349124-98321239-18BE-4239-8B10-B8D26400F4C3Q48613858-85891F2E-FB04-4790-974F-EF68C1B7FCD2Q51836466-ECF58DA1-4BBE-43D7-AC9E-AEFA3A350B4AQ57378488-FE725E4B-7386-42EF-A04C-F45F88B584B2
P2860
Systemic linoleic and gamma-linolenic acid therapy in dry eye syndrome with an inflammatory component.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
Systemic linoleic and gamma-li ...... ith an inflammatory component.
@en
Systemic linoleic and gamma-li ...... ith an inflammatory component.
@nl
type
label
Systemic linoleic and gamma-li ...... ith an inflammatory component.
@en
Systemic linoleic and gamma-li ...... ith an inflammatory component.
@nl
prefLabel
Systemic linoleic and gamma-li ...... ith an inflammatory component.
@en
Systemic linoleic and gamma-li ...... ith an inflammatory component.
@nl
P2093
P1433
P1476
Systemic linoleic and gamma-li ...... with an inflammatory component
@en
P2093
Giambattista Ravera
Giovanni Calabria
Paola Camicione
Sabrina Zanardi
Sebastiano Giuffrida
Stefano Barabino
P304
P356
10.1097/00003226-200303000-00002
P577
2003-03-01T00:00:00Z